Skip to main content
. 2020 Aug 13;2020(8):CD005552. doi: 10.1002/14651858.CD005552.pub3

Summary of findings 5. Metformin compared to metformin combined with oral contraceptive pill (OCP) for hirsutism, acne and menstrual pattern in adolescent women with polycystic ovary syndrome (PCOS).

Metformin compared to metformin combined with OCP for hirsutism, acne and menstrual pattern in adolescent women with PCOS
Patient or population: adolescent women with PCOS
Setting: Hospital or University Clinics
Intervention: metformin
Comparison: metformin combined with OCP
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) No of participants
(studies) Quality of the evidence
(GRADE) Comments
Risk with metformin combined with OCP Risk with metformin
Hirsutism ‐ Clinical F‐G score   No trials reported on outcome "Hirsutism ‐ Clinical F‐G score"
Adverse event ‐ Severe Gastro‐intestinal No trials reported on outcome "Adverse event ‐ Severe ‐ Gastro‐intestinal"
Others No trials reported on outcome "Adverse event ‐ Severe ‐ Others"
Adverse event ‐ Minor Gastro‐intestinal No trials reported on outcome "Adverse event ‐ Minor ‐ Gastro‐intestinal"
Others No trials reported on outcome "Adverse event ‐ Minor ‐ Others"
Improved menstrual pattern Shortening of inter menstrual day No trials reported on outcome "Improved menstrual pattern (i.e. shortening of intermenstrual days)"
An initiation of menses or cycle regularity No trials reported on outcome "Improved menstrual pattern (i.e. an initiation of menses or cycle regularity)"
Acne ‐ Visual analogue scale or Clinical acne score   No trials reported either on outcome "Acne ‐ Visual analogue scale" or "Acne ‐ Clinical acne score"
BMI (kg/m2)   No trials reported on outcome "BMI"
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

BMI: body mass index; CI: Confidence interval; F‐G: Ferriman‐Gallwey score; MD: Mean difference; OR: Odds ratio
GRADE Working Group grades of evidenceHigh quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.